Abstract
Screening of a non-ionizable compound library and hit optimization studies has resulted in a series of compounds based on a 4-arylmethyl-3-(4- carboxyphenyl)-5-hydroxyisoxazole scaffold with GCP II inhibitory activity in the low micromolar range.
Original language | English |
---|---|
Pages (from-to) | 29-32 |
Number of pages | 4 |
Journal | Letters in Drug Design and Discovery |
Volume | 6 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2009 |
Externally published | Yes |
Keywords*
- 5-hydroxyisoxazole
- Glutamate
- Glutamate carboxypeptidase II
- Lipophilicity
- Synthesis
Field of Science*
- 3.1 Basic medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database